Methadone Hydrochloride Market Size, Share, Growth, and Industry Analysis by Type (Molecular Formula, Other Types), By Application (Methadone Hydrochloride Tablet, Methadone Hydrochloride Oral Solution, and Others), Regional Insights, and Forecast To 2031

Updated On: 08 April 2024

Methadone Hydrochloride Market Report Overview

• 

• Request a Free Sample to learn more about this report

The global methadone hydrochloride market size was USD 64 million in 2021 and is projected to touch USD 102.44 million by 2031, at a CAGR of 4.8% during the forecast period.

One type of opioid is the synthetic narcotic analgesic methadone. The pharmacologic effects of this opioid are qualitatively comparable to morphine. Methadone is typically used to treat pain and as part of a maintenance and detoxification programme for drug addiction. One of the most well-known phenomena is pain, which is said to affect 85% of people worldwide at some time in their lives. Pain can be caused by a variety of things, including surgery, strain, and other things. Methadone hydrochloride, which is utilized in various formulations and strengths of 5 mg/5 ml, 10 mg/ml for oral administration, and 10 mg/ml solution for parenteral administration, is categorized as a mu receptor agonist present in the central nervous system.

"COVID-19 Impact: Supply and Demand Chain were Disrupted Due to Restrictions Imposed"

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

Every market in the globe has been touched by COVID-19, and this includes the market for methadone hydrochloride globally. As a result, governments around the world are pursuing a variety of actions to combat COVID-19. For instance, the Centers for Disease Control and Prevention began collaborating with governmental organizations and academic institutions in May 2020 to strengthen case detection, contact tracing, and testing capability throughout all states in the U.S. and to reopen the nation. Furthermore, some nations have increased low-threshold services and lowered obstacles to obtaining opiate-substitution drugs in response to a decrease in the accessibility of COVID-19 treatment service provision during the lockdown. For example, the U.K. now permits pharmacies to dispense methadone. The U.K. intends to give methadone to those who already use it without a new prescription in order to increase access to opioid-substitution therapy, but the move has raised concerns from the Advisory Council on the Misuse of Drugs that it would promote drug abuse and diversion.

LATEST TRENDS

"Utilization as an Analgesic to Inflate the Market Demand"

When treating chronic pain, methadone is frequently used in combination with other opioids. It may be more effective against neuropathic pain because of its NMDA receptor activation, and it may also cause less tolerance to the analgesic effects than other opioids. Due to its extended half-life and little risk to the patient, methadone has shown to be an effective substitute for morphine sulphate and other opiate analgesics.

Methadone Hydrochloride Market Segmentation

• 

• Request a Free Sample to learn more about this report

• By Type

Based on type; the methadone hydrochloride market is divided into molecular formula and others.

• By Application

Based on the application; the methadone hydrochloride market is divided into methadone hydrochloride tablet, methadone hydrochloride oral solution and others.

DRIVING FACTORS

"Increasing Prevalence of Pain Associated with Therapeutic and Post-surgical Treatment to Boost Market Share"

The methadone market is anticipated to expand due to the rising prevalence of the new pain that comes with therapeutic and post-surgical treatments of cancer and other chronic diseases. Patients who are instructed to take painkillers continuously for a prolonged period of time and who are unable to be treated with alternative drug options use methadone to address their severe pain. Furthermore, methadone maintenance therapy, which entails giving patients who are dependent on opiates long-term doses of methadone formulation, is a major driver of the methadone business. All of these elements contribute to the growing methadone market.

"Increasing Drug Use Globally to Drive the Market Growth"

Opioid use disorders are treated with methadone. It can be used for shorter periods during detoxification or as maintenance therapy to treat opioid withdrawal symptoms. Usually, it is highly controlled in how it is used to treat addiction. In order to prescribe methadone for opioid addiction in the US, outpatient treatment centers must be accredited by the federal Substance Abuse and Mental Health Services Administration (SAMHSA) and registered with the Drug Enforcement Administration (DEA). According to a 2009 Cochrane study, methadone was beneficial in keeping patients in treatment and in reducing or stopping heroin use, as determined by self-report and urine/hair tests. However, it had no effect on criminal activity or the risk of mortality.

RESTRAINING FACTORS 

"Toxicity and Hazardous Nature to Restrain the Market"

The use of methadone hydrochloride is accompanied by a number of side effects, including constipation, nausea, sleepiness, vomiting, exhaustion, headache, dizziness, and stomach discomfort. Patients also run the risk of developing a methadone addiction. In the upcoming years, a few things could prevent the global market from expanding. Due to various hazards involved with using methadone, individuals with severe asthma or respiratory issues may limit their use, which could reduce the market for methadone. In addition, methadone abuse, such as overdosing or quitting the medication without a doctor's approval, can cause a rapid heartbeat, hallucinations, and difficulty breathing. This can also prevent the methadone hydrochloride market from expanding.

Methadone Hydrochloride Market Regional Insights

• 

• Request a Free Sample to learn more about this report

"Asia Pacific Region to Lead the Market with Volume Production"

Due to the higher frequency of chronic pain associated with cancer and post-surgical pain, the North American region is predicted to hold the leading position in the worldwide methadone hydrochloride market share. Over 1 in 5 persons in the United States reported chronic pain in 2018, according to the Centers for Disease Control and Prevention (CDC) report. The expanding prevalence of pain and rising demand for methadone for maintenance and detoxification therapy are factors that are being used to explain the expansion of the regional market. Furthermore, the presence of important vendors operating in the North America market is a key determinant for methadone hydrochloride market growth.

KEY INDUSTRY PLAYERS

"Key Industry Players to Promote the Market Expansion"

The market's expansion was significantly impacted by the techniques employed by market participants in recent years, such as extensions. The report covers details and information about the firms and their interactions with the market. The data is gathered and published through appropriate research, technological advancements, expansions, and expanding machinery and equipment. Other considerations taken into account for this market are the businesses that develop and provide new products, the geographic areas in which they function, mechanization, innovation strategies, generating the maximum revenue, and using their products to make a significant difference.

List of Market Players Profiled

• Eli Lilly (U.S.)
• Sanofi (France)
• Roxane Laboratories (U.S.)
• Mallinckrodt (Ireland)
• Siegfried Ltd (Switzerland)
• MACFARLAN SMITH (U.K)
• Tianjin Central Pharma (China)

REPORT COVERAGE

This report covers a comprehensive backdrop analysis, an assessment of the parent market, intensive study in the market dynamics. Past historical, current, and projected size of the market from the point of both value and volume. Researching of recent industry developments,  deep study on market shares and strategies of major players and the emerging niche segments and regional market areas are covered in the report.